Implantable medical devices market seen reaching $148.9 billion by 2030

The Business Research Company says the global implantable medical devices market will grow from $109.97 billion in 2025 to $117.13 billion in 2026, then climb to $148.87 billion by 2030. The forecast points to rising demand for minimally invasive surgery, smarter implants and customized devices as key growth drivers.

Why it matters: - Implantable medical devices are becoming more central to long-term treatment, monitoring and replacement of biological functions. - Market growth signals stronger demand for devices that can improve outcomes, shorten recovery times and support more precise care. - The forecast also points to faster adoption of newer implant technologies, including bioresorbable and smart implants.

What happened: - The Business Research Company published its Implantable Medical Devices Market Report 2026, covering market size, trends and global forecasts for 2026-2035. - The report estimates the market will rise from $109.97 billion in 2025 to $117.13 billion in 2026, a 6.5% CAGR. - The market is projected to reach $148.87 billion by 2030, growing at a 6.2% CAGR over the forecast period. - The report is available through a full market report and a free sample.

The details: - Implantable medical devices are surgically inserted into the body to support, monitor or replace biological functions. - These devices can be temporary or permanent, depending on their purpose. - Recent market growth has been linked to limited availability of advanced implant materials, reliance on metallic and polymer implants, higher rates of cardiovascular and orthopedic disease, more surgical procedures and greater awareness of implant-based therapies. - Future growth is expected to come from bioresorbable and smart implants, patient-specific designs, minimally invasive surgery, cochlear and neural interface applications, and artificial intelligence paired with digital monitoring. - The report highlights rising adoption of cardiovascular and orthopedic implants, more minimally invasive implant surgeries, broader use of neurostimulators and drug delivery implants, personalized implant design and tighter safety compliance. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables.

Between the lines: - The strongest demand signal is the shift toward less invasive procedures that reduce trauma, pain and recovery time. - The report frames implantable devices as part of a broader move toward personalized and digitally monitored care. - The regional outlook suggests mature markets still lead on adoption, while faster growth is shifting toward regions with expanding healthcare access and investment. - A cited example from the American Society of Plastic Surgeons showed U.S. cosmetic minimally invasive procedures rose 7% in 2023 to 25,442,640 procedures, reinforcing demand for related device categories.

What's next: - The market is expected to keep expanding as hospitals and device makers adopt smarter, more customized implants. - Growth will likely be shaped by advances in minimally invasive techniques, artificial intelligence integration and stricter safety regulation. - The Business Research Company is offering more report access and sales contact options through its published materials and media channels.

The bottom line: - Implantable medical devices are moving from a steady-growth category to a technology-led market shaped by personalization, minimally invasive care and digital monitoring.